Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle

Behavioural Brain Research

Volumn 216, Issue 1, 2011, Pages 381-388

  Monti, Jaime M ^a   Jantos, Héctor ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

EMD 281014; Light dark cycle; REM sleep; RO 4368554; SB 399885; Serotonin 5 HT2A receptor; Serotonin 5 HT6 receptor; Slow wave sleep; Wakefulness

Indexed keywords

[3 BENZENESULFONYL 7 (4 METHYL PIPERAZIN 1 YL) 1H INDOLE]; N (3,5 DICHLORO 2 METHOXYPHENYL) 4 METHOXY 3 (1 PIPERAZINYL)BENZENESULFONAMIDE; PRUVANSERIN; RO 4368554; SEROTONIN 2A ANTAGONIST; SEROTONIN 6 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LIGHT DARK CYCLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REM SLEEP; SLEEP; SLOW WAVE SLEEP; WAKEFULNESS;

ANALYSIS OF VARIANCE; ANIMALS; ELECTROENCEPHALOGRAPHY; INDOLES; MALE; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SLEEP; SULFONAMIDES; WAKEFULNESS;

EID: 78149415099     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.08.020     Document Type: Article

References (38)

1. 1B agonist. CGS 12066B, on sleep/waking stages and EEG power spectrum in rats. J Sleep Res 1994, 3:97-105.
2. 1B knock-out mice. Neuroscience 1999, 19:3204-3212.
3. Cooper J.R., Bloom F.E., Roth R.H. The biochemical basis of neuropharmacology 1990, Oxford University Press, Oxford, p. 352-409. 7th ed.
4. Dawson L.A., Nguyen H.Q., Li P. In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 2000, 130:23-26.
5. Dawson L.A., Nguyen H.Q., Li P. The 5-HT6 antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 2001, 25:662-668.
6. 2 receptor could be primarily involved in the regulation of slow wave sleep in the rat. Eur J Pharmacol 1987, 137:145-146.
7. Grant L., Hopkinson P., Jennings G., Jenner F.A. Period of adjustment of rats used for experimental studies. Nature 1971, 232:135.
8. 7 receptor antagonist. Br J Pharmacol 2000, 130:539-548.
9. Halperin J.M., Miller D., Iorio L.C. Sleep inducing effects of three hypnotics in a new model of insomnia in rats. Pharmacol Biochem Behav 1981, 14:811-814.
10. Jones B.E. Arousal systems. Front Biosci 2003, 8:S438-S451.
11. 6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Brain Res Mol Brain Res 2001, 90:110-117.
12. 6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 2003, 51:158-164.
13. Michaud J.C., Muyard J.P., Capdevielle G., Ferran E., Geiordano-Orsini J.P., Veyrun J., et al. Mild insomnia induced by environmental perturbations in the rat: a study of this new model and of its possible applications in pharmacological research. Arch Int Pharmacol Ther 1982, 259:93-105.
14. 6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 2005, 108:320-333.
15. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993, 43:320-327.
16. Monti J.M. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the l-dopa and (+)-amphetamine-induced waking EEG in the rat. Br J Pharmacol 1979, 67:87-91.
17. 2A receptor antagonists in the treatment of insomnia: present status and future prospects. Drugs Today 2010, 46:183-193.
18. 1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behav Brain Res 2004, 151:159-166.
19. 2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. Eur J Pharmacol 2006, 553:163-170.
20. Monti J.M., Hawkins M., Jantos H., D'Angelo L., Fernández M. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 1988, 95:395-400.
21. Monti J.M., Piñeyro G., Orellana C., Boussard M., Jantos H., Labraga P., et al. 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat. Biogen Amines 1990, 7:145-151.
22. 1B receptor with CP-94253 on sleep and wakefulness in the rat. Neuropharmacology 1995, 34:1647-1651.
23. Monti J.M., Jantos H., Monti D. Serotonin and sleep-wake regulation. Neurochemistry of sleep and wakefulness 2008, 244-279. Cambridge University Press, Cambridge. J.M. Monti, S.R. Pandi-Perumal, C.M. Sinton (Eds.).
24. Monti J.M., Jantos H. Mechanisms involved in the inhibition of REM sleep by serotonin. Serotonin and sleep: molecular, functional and clinical aspects 2008, 371-385. Birkhäuser Verlag, Basel. J.M. Monti, S.R. Pandi-Perumal, B.L. Jacobs, D.J. Nutt (Eds.).
25. 6 receptor antagonists promote sleep in rats. Sleep 2008, 31:34-44.
26. 3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. Eur J Pharm 1993, 249:259-264.
27. 2A receptors. J Neurosci 2005, 25:1123138.
28. Radulovacki M., Miletich R.S., Green R.D. N6 (l-phenylisopropyl)adenosine) (l-PIA) increases slow wave sleep (S2) and decreases wakefulness in rats. Brain Res 1982, 246:178-180.
29. 6 receptor antagonist. J Med Chem 2003, 46:1273-1276.
30. 125I]SB-258585. Brain Res 2002, 934:49-57.
31. Ruat M., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Diaz J., Leurs R., et al. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 1993, 193:268-276.
32. 6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 2008, 33:1323-1335.
33. Sleight A.J., Consolo S., Martin J.R., Boes F.G., Boess J.C., Bentley J.C., et al. 5-HT6 receptors: functional correlates and potential therapeutic indications. Behav Pharmacol 1999, 10:S86.
34. Szymusiak R., Gvilia I., McGinty D. Hypothalamic control of sleep. Sleep Med 2007, 8:291-301.
35. 7 receptor antagonist, inhibits REM sleep in rats. Br J Pharmacol 2003, 139:705-714.
36. Verret L., Goutagny R., Fort P., Cagnon L., Salvert D., Léger L., et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 2003, 4:19.
37. Wolley M.L., Marsden C.A., Sleight A.J., Fone K. Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, RO-046790, in rats. Br J Pharmacol 2000, 129:64P.
38. 6 receptors. Curr Drug Targets CNS Neurol Disord 2004, 3:59-79.